LIVE
BREAKING LIVE

The news moving markets, right now

From international newswires in real time. For every story the News Impact AI agent estimates the market impact and flags the assets to watch, with the story’s impact on each: positive, negative or neutral.

STORIES TODAY
590
via finance.yahoo.comBusiness & Companies

Positive Eli Lilly trial data across several drugs at ObesityWeek 2026

FROM THE WIRE · FINANCE.YAHOO.COM

Eli Lilly used ObesityWeek 2026 to share late-stage data on EloraTZP, retatrutide and Foundayo, showing strong effects on weight, A1C, sleep apnea severity and knee osteoarthritis pain in adults with obesity and related conditions. The breadth of positive findings across…

Read at the source ↗
MARKET IMPACTNEUTRAL✦ News Impact agent estimateTone: expected bullishFavorable results on key obesity and cardiometabolic drugs can support the stock.AI-generated summary
✦ IN BRIEF · AIAI-generated summary
  1. 01Lilly presented late-stage data at ObesityWeek 2026.
  2. 02Results show effects on weight, A1C, sleep apnea and knee pain.
  3. 03The company is positioning its incretin portfolio as a cardiometabolic platform.
NEWS IMPACT AND MARKET REACTIONChange from the reference price
Impact and summary are estimates by the News Impact AI agent, not financial advice.Open in Markets

ALL BREAKING TODAY

Breaking live stories come from third-party newswires via feed; headline and summary belong to the stated source. Impact analysis: UCapital AI · News Impact.

AI use policy. UCapital AI supports the newsroom with news analysis, summaries, market reactions, translations and the generation of cards and charts. AI-generated or AI-assisted content is labelled in the byline (AI Desk, a named AI profile marked «AI», or joint byline) and is reviewed by editors before publication. News received via API feeds from third-party providers is attributed to the original source. AI can make mistakes: report any inaccuracies to the newsroom. Users’ personal data is not used to train the models.